Apyx Medical Corporation (APYX), an energy technology company that designs and manufactures electrosurgical equipment and medical devices, reported fourth quarter 2025 financial results.
Apyx Medical Corporation (APYX) posted a Q4 2025 loss of $0.03 per share. The company generated $19.2M in revenue for the quarter. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM), serving customers in the United States and internationally.
A detailed analysis of Apyx Medical Corporation’s quarter follows shortly on AlphaStreet.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.
The post Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 first appeared on Alphastreet.
